FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Atraverses Hotwire Radiofrequency Guidewire Cleared

FDA clears an Atraverse Medical 510(k0 for its Hotwire radiofrequency guidewire, a device that enables zero exchange left-heart access.

latest-news-card-1
Medical Devices

Abbott Recalls HeartMate 3 Pump Over Leaks

Abbott recalls (Class 1) its HeartMate 3 LVAS after reviewing complaints that identified blood or air leakages.

latest-news-card-1
Biologics

Complete Response Letter for 4-Dose Heplisav-B

FDA issues a complete response letter for a Dynavax sBLA for a new indication for its Heplisav-B hepatitis vaccine.

latest-news-card-1
Medical Devices

Indica Labs Digital Pathology Platform Cleared

FDA clears an Indica Labs 510(k) for HALO AP Dx, a digital pathology platform that the company says enables slides to be reviewed from any location as...

latest-news-card-1
Federal Register

Animal Drug Regs Amended for Approvals

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for made during January, February, and March.

latest-news-card-1
Medical Devices

Expiry Dates Extended on CTK Bios Covid Tests

FDA says CTK Biotechs ImmuView Covid-19 Antigen Home Test now has a longer shelf life than previously authorized.

latest-news-card-1
Human Drugs

Ascendis Pharma NDA Review Extended

FDA extends by three months its review of an Ascendis Pharma NDA for TransCon PTH (palopegteriparatide) due to the companys submission of additional i...

latest-news-card-1
Human Drugs

CGMP Violations in Grupo Contract Test Lab

FDA warns Uruguays Grupo Quimico SRL about CGMP violations in its work as a contract testing laboratory for drug companies.

latest-news-card-1
Federal Register

Day One Bio Granted Pediatric Voucher

Federal Register notice: FDA announces that it issued Day One Biopharmaceuticals a priority review voucher for its recently approved pediatric disease...

latest-news-card-1
Human Drugs

FDA Clears Qiagens Respiratory Panel Plus

FDA clears a Qiagen 510(k) for the QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use in diagnosing upper respiratory infections and co...